The Kathleen Berkner lab studies gamma-glutamyl carboxylation of vitamin K-dependent proteins.
The Leslie Bruggeman lab investigates the molecular and cellular biology of chronic kidney disease.
The Scott Cameron lab researches blood platelet reprogramming for vascular and thrombotic disorders.
Dr. Lai (Linda) Chan’s lab studies oncogenic signaling and metabolic reprogramming to understand how they influence cancer development and progression.
The Olga Cherepanova lab studies phenotypic transition of vascular cells during atherosclerosis development and after injury.
The Seth Corey lab studies bone marrow failure, myelodysplastic syndromes and myeloid malignancies.
The Dwidar lab studies the use of microbes for medical purposes, including engineering microbes as therapeutic and diagnostic tools for diseases, such as different cancers.
The Paul Fox lab studies IFN-gamma signaling, mechanisms of blood vessel formation and ferroxidases in iron metabolism.
The Lynn Hajjar lab studies how microbiota alter immune responses and impact health and disease.
The Stanley Hazen lab studies how inflammation contributes to cardiovascular diseases and the microbiome’s role in heart health.
The Sadashiva Karnik lab AT1R structure, function, physiology, genetics and signaling.
The Robert Koeth lab studies pathways in arrhythmogenesis and development of cardiac arrhythmias.
The Jaroslaw Maciejewski lab studies the pathophysiology of bone marrow failure syndromes, including myelodysplastic syndromes.
The Keith McCrae lab studies the function of blood vessels in health and disease.
The McIntyre lab studies how cells respond to external stimuli, specifically in the vascular system.
The Christine Moravec lab investigates physiological and biomechanical changes and psychophysiologic remodeling in heart failure.
The Ina Nemet lab focuses on understanding the communication between gut microorganisms and their host.
The Edward Plow lab studies the central properties of integrins in inflammation and angiogenesis.
The Prasad lab studies protein regulation and how it may be targeted for new heart failure treatments.
The Jun Qin lab studies key protein-protein interactions in heart failure, diabetes and cancer.
The Yogen Saunthararajah lab studies how to selectively target and eliminate cancer cells without harming healthy cells.
The Schumacher-Bass lab investigates heart failure and signaling mechanisms, including G protein-coupled receptors.
Dr. Richa Sharma’s lab at Cleveland Clinic studies DNA repair and telomere biology to uncover mechanisms of cancer predisposition and bone marrow failure.
The Jonathan Smith lab studies cardiovascular diseases including atherosclerosis, atrial fibrillation and HDL metabolism.
The Wai Hong Wilson Tang lab studies determinants of cardiovascular disease, particularly in human heart failure and cardiomyopathy.
The Van Wagoner lab studies how genetic variations lead to increased risk of atrial fibrilation.
The Oliver Wessely lab studies kidney development and diseases.